357
Views
7
CrossRef citations to date
0
Altmetric
Cornea

Mitochondrial Profile and Responses to TGF-β Ligands in Keratoconus

, &
Pages 900-907 | Received 19 Mar 2015, Accepted 25 Jul 2015, Published online: 02 Oct 2015

References

  • Dianov GL, Souza-Pinto N, Nyaga SG, Thybo T, Stevnsner T, Bohr VA. Base excision repair in nuclear and mitochondrial DNA. Prog Nucleic Acid Res Mol Biol 2001;68:285–297.
  • de Souza-Pinto NC, Mason PA, Hashiguchi K, Weissman L, Tian J, Guay D, et al. Novel DNA mismatch-repair activity involving YB-1 in human mitochondria. DNA Repair 2009;8:704–719.
  • Ingman M, Kaessmann H, PaÈaÈbo S, Gyllensten U. Mitochondrial genome variation and the origin of modern humans. Nature 2000;408:708–713.
  • Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717–719.
  • Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza A, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 1988;242:1427–1430.
  • McFarland R, Taylor R, Turnbull D. Mitochondrial disease—its impact, etiology, and pathology. Curr Top Dev Biol 2007;77:113–155.
  • Schaefer AM, McFarland R, Blakely EL, He L, Whittaker RG, Taylor RW, et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008;63:35–39.
  • McBride HM, Neuspiel M, Wasiak S. Mitochondria: more than just a powerhouse. Curr Biol 2006;16:R551–R560.
  • Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia–reperfusion, aging, and heart failure. J Mol Cell Cardiol 2001;33:1065–1089.
  • Zeviani M, Di Donato S. Mitochondrial disorders. Brain 2004;127:2153–2172.
  • Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005;6:389–402.
  • Sherer TB, Betarbet R, Greenamyre JT. Environment, mitochondria, and Parkinson’s disease. Neuroscientist 2002;8:192–197.
  • Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol 2007;83:84–92.
  • Schrier SA, Falk MJ. Mitochondrial disorders and the eye. Curr Opin Ophthalmol 2011;22:325.
  • Nordan LT. Keratoconus: diagnosis and treatment. Int Ophthalmol Clin 1997;37:51–63.
  • Edrington T, Zadnik K, Barr J. Keratoconus. Optom Clin 1994;4:65–73.
  • Karamichos D, Hutcheon AE, Rich CB, Trinkaus-Randall V, Asara JM, Zieske JD. In vitro model suggests oxidative stress involved in keratoconus disease. Sci Rep 2014;4. doi:10.1038/srep04608
  • Rahi A, Davies P, Ruben M, Lobascher D, Menon J. Keratoconus and coexisting atopic disease. Br J Ophthalmol 1977;61:761–764.
  • Gasset A, Hinson W, Frias J. Keratoconus and atopic diseases. Ann Ophthalmol 1978;10:991–994.
  • Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br J Ophthalmol 2000;84:834–836.
  • Cullen J, Butler H. Mongolism (Down’s syndrome) and keratoconus. Br J Ophthalmol 1963;47:321.
  • Shapiro MB, France TD. The ocular features of Down’s syndrome. Am J Ophthalmol 1985;99:659–663.
  • Robertson I. Keratoconus and the Ehlers-Danlos syndrome: a new aspect of keratoconus. Med J Aust 1975;1:571–573.
  • Woodward E, Morris M. Joint hypermobility in keratoconus. Ophthal Physl Opt 1990;10:360–362.
  • Pathak D, Nayak B, Singh M, Sharma N, Tandon R, Sinha R, et al. Mitochondrial complex 1 gene analysis in keratoconus. Mol Vis 2011;17:1514.
  • Abu-Amero KK, Azad TA, Kalantan H, Sultan T, Al-Muammar AM. Mitochondrial sequence changes in keratoconus patients. IOVS 2014;55:1706–1710.
  • Wojcik KA, Kaminska A, Blasiak J, Szaflik J, Szaflik JP. Oxidative stress in the pathogenesis of keratoconus and Fuchs endothelial corneal dystrophy. Int J Mol Sci 2013;14:19294–19308.
  • Atilano SR, Coskun P, Chwa M, Jordan N, Reddy V, Le K, et al. Accumulation of mitochondrial DNA damage in keratoconus corneas. IOVS 2005;46:1256–1263.
  • Karamichos D, Zieske J, Sejersen H, Sarker-Nag A, Asara JM, Hjortdal J. Tear metabolite changes in keratoconus. Exp Eye Res. 2015; 132:1–8.
  • Balasubramanian SA, Wasinger VC, Pye DC, Willcox MD. Preliminary identification of differentially expressed tear proteins in keratoconus. Mol Vis 2013;19:2124–2134.
  • Karamichos D, Zareian R, Guo X, Hutcheon AE, Ruberti JW, Zieske JD. Novel in vitro model for keratoconus disease. J Funct Biomater 2012;3:760–775.
  • Karamichos D, Hutcheon A, Zieske J. Reversal of fibrosis by TGF-β3 in a 3D in vitro model. Exp Eye Res 2014;124:31–36.
  • Karamichos D, Rich CB, Zareian R, Hutcheon AE, Ruberti JW, Trinkaus-Randall V, et al. TGF-β3 stimulates stromal matrix assembly by human corneal keratocyte-like cells. IOVS 2013;54:6612–6619.
  • Karamichos D, Hutcheon A, Zieske J. Transforming growth factor-β3 regulates assembly of a non-fibrotic matrix in a 3D corneal model. J Tissue Eng Regen Med 2011;5:e228–e238.
  • Gatherer D, Ten Dijke P, Baird D, Akhurst R. Expression of TGF-beta isoforms during first trimester human embryogenesis. Development 1990;110:445–460.
  • Millan FA, Denhez F, Kondaiah P, Akhurst RJ. Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. Development 1991;111:131–143.
  • Pelton R, Dickinson M, Moses H, Hogan B. In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. Development 1990;110:609–620.
  • Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991;115:1091–1105.
  • Schmid P, Cox D, Bilbe G, Maier R, McMaster GK. Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development 1991;111:117–130.
  • Hijikata M, Kato N, Sato T, Kagami Y, Shimotohno K. Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol 1990;64:4632–4639.
  • Jansson AK, Emterling AM, Arbman G, Sun X-F. Noxa in colorectal cancer: a study on DNA, mRNA and protein expression. Oncogene 2003;22:4675–4678.
  • Dejean LM, Martinez-Caballero S, Manon S, Kinnally KW. Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta 2006;1762:191–201.
  • Reed JC, Zha H, Aime-Sempe C, Takayama S, Wang HG. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. Adv Exp Med Biol 1996;406:99–112.
  • Liu J, Li J, Li W-J, Wang C-M. The role of uncoupling proteins in diabetes mellitus. J Diabetes Res 2013. doi:10.1155/2013/585897
  • Park K-P, Kim H-S, Kim E-S, Park Y-E, Lee C-H, Kim D-S. SLC25A4 and C10ORF2 mutations in autosomal dominant progressive external ophthalmoplegia. J Clin Neurol 2011;7:25–30.
  • Li Y, Huang T-T, Carlson EJ, Melov S, Ursell PC, Olson JL, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 1996;11:376–381.
  • Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol genomics 2003;16:29–37.
  • Barr JT, Wilson BS, Gordon MO, Rah MJ, Riley C, Kollbaum PS, et al. Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea 2006;25:16–25.
  • Liu L, Walker EA, Kissane S, Khan I, Murray PI, Rauz S, et al. Gene expression and miR profiles of human corneal fibroblasts in response to dexamethasone. IOVS 2011;52:7282–7288.
  • Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q. Role of carnitine in disease. Nutr Metab 2010;7:30.
  • Walker JE. The mitochondrial transporter family. Curr Opin Struct Biol 1992;2:519–526.
  • Porter RK. Mammalian mitochondrial inner membrane cationic and neutral amino acid carriers. Biochim Biophys Acta 2000;1459:356–362.
  • Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000;288:1053–1058.
  • Liu C, Ogando D, Bonanno JA. SOD2 contributes to anti-oxidative capacity in rabbit corneal endothelial cells. Mol Vis 2011;17:2473.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.